Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series
Our findings demonstrate that sequential therapy provides effective symptom management and long-term disease control. Further, CA125 remains a valuable biomarker for monitoring therapeutic success.
Authors
- Kohei Takehara
- Takayuki Ichinose
- Takako Onodera
- Haruka Nishida (ORCID: https://orcid.org/0000-0002-4790-8281)
- Saya Watanabe
- Kazunori Nagasaka (ORCID: https://orcid.org/0000-0002-0696-5175)
- Kazuki Takasaki (ORCID: https://orcid.org/0000-0001-6671-1858)
- Yuko Takahashi (ORCID: https://orcid.org/0000-0003-3421-1212)
- Haruko Hiraike
- Mana Hirano
Institutions
- Teikyo University (JP)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1186/s12905-025-03681-8
- Citations
- 2
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.40